微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Amycolatopsis rifamycinica |
|---|---|
| 商品货号： | TS182414 |
| Deposited As： | Streptomyces mediterranei Margalith and Beretta |
| Strain Designations： | M 18 |
| Application： | Produces rifamycin B nancimycin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1877: ISP Medium 1 ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Gruppo Lepetit S.p.A. |
| U.S. Patent Number： | |
| References： | White RJ, Lancini G. Production of rifamycin B. US Patent 3,871,965 dated Mar 18 1975 Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986. Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 |